Correlation Between Alnylam Pharmaceuticals and Wave Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Wave Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Wave Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Wave Life Sciences, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Wave Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Wave Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Wave Life.

Diversification Opportunities for Alnylam Pharmaceuticals and Wave Life

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Alnylam and Wave is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Wave Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wave Life Sciences and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Wave Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wave Life Sciences has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Wave Life go up and down completely randomly.

Pair Corralation between Alnylam Pharmaceuticals and Wave Life

Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 2.75 times less return on investment than Wave Life. But when comparing it to its historical volatility, Alnylam Pharmaceuticals is 2.33 times less risky than Wave Life. It trades about 0.07 of its potential returns per unit of risk. Wave Life Sciences is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  401.00  in Wave Life Sciences on November 3, 2024 and sell it today you would earn a total of  756.00  from holding Wave Life Sciences or generate 188.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.6%
ValuesDaily Returns

Alnylam Pharmaceuticals  vs.  Wave Life Sciences

 Performance 
       Timeline  
Alnylam Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alnylam Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Alnylam Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Wave Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Wave Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Alnylam Pharmaceuticals and Wave Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alnylam Pharmaceuticals and Wave Life

The main advantage of trading using opposite Alnylam Pharmaceuticals and Wave Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Wave Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wave Life will offset losses from the drop in Wave Life's long position.
The idea behind Alnylam Pharmaceuticals and Wave Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing